AS01(B)-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a post-hoc cross-protocol comparison of results from HVTN 100, 107, 120, and 702.
- DOI
- 10.3389/fimmu.2026.1768201
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1768201,
title = {AS01(B)-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a post-hoc cross-protocol comparison of results from HVTN 100, 107, 120, and 702.},
author = {Menezes F and Chen S and Grunenberg N and Malahleha M and Mngadi K and Muyoyeta M and Laher F and Chirenje ZM and Bekker LG and Goepfert P and Gray GE and Tomaras G and McElrath MJ and Kallas E and Roxby AC and Moodie Z},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1768201},
url = {https://doi.org/10.3389/fimmu.2026.1768201}
}RIS
TY - JOUR TI - AS01(B)-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a post-hoc cross-protocol comparison of results from HVTN 100, 107, 120, and 702. AU - Menezes F AU - Chen S AU - Grunenberg N AU - Malahleha M AU - Mngadi K AU - Muyoyeta M AU - Laher F AU - Chirenje ZM AU - Bekker LG AU - Goepfert P AU - Gray GE AU - Tomaras G AU - McElrath MJ AU - Kallas E AU - Roxby AC AU - Moodie Z PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1768201 UR - https://doi.org/10.3389/fimmu.2026.1768201 ER -
APA
F, M., S, C., N, G., M, M., K, M., M, M., F, L., ZM, C., LG, B., P, G., GE, G., G, T., MJ, M., E, K., AC, R., & Z, M. (2026). AS01(B)-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a post-hoc cross-protocol comparison of results from HVTN 100, 107, 120, and 702.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1768201
Source records
- pubmed · retrieved 2026-09-25T13:59:34.531Z